|
Aβ42/40 ratio < 0.068
|
Aβ42/40 ratio ≥ 0.068
|
---|
LL (n = 59)
|
10 (17%)—IAP
|
49 (83%)—LL
|
IAP (n = 21)
|
14 (67%)—IAP
|
7 (33%)—LL
|
SNAP (n = 55)
|
36 (66%)—HL
|
19 (34%)—SNAP
|
HL (n = 62)
|
56 (90%)—HL
|
6 (10%)—SNAP
|
- Data expressed as n (percentage) of patients
- Aβ42/40 42-aminoacid isoform of amyloid beta/40-aminoacid isoform of amyloid beta, LL Low-AD likelihood, IAP isolated amyloid pathology, SNAP suspected non-Alzheimer pathology, HL high-AD likelihood, AD Alzheimer’s disease